Here, we show that activation of mTOR of ACD patients contributes to sustain IL-15 production since inhibition of mTORC1 with rapamycin in cultures of ACD mucosal samples reduced IL-15 synthesis. Here, MTOR is linked to granular corneal dystrophy type II.